desototimes.comOpinion

Is God Dead? Is Christianity a Copycat?

Is Christianity just a copycat religion? Many critics answer, “Yes,” and argue that much of the Old Testament is nothing more ...
STAT

AbbVie to buy Gilgamesh’s psychedelic drug for up to $1.2 billion

Elaine Chen covers biotech, co-writes The Readout newsletter, and co-hosts STAT’s weekly biotech podcast, The Readout Loud. You can reach Elaine on Signal at elaineywchen.70. AbbVie on Monday said it ...
Nasdaq

AbbVie to Acquire Gilgamesh Pharmaceuticals' Bretisilocin, a Novel, Investigational Therapy for Major Depressive Disorder, Expanding Psychiatry Pipeline

Gilgamesh's lead asset, bretisilocin (GM-2505), is a potential best-in-class psychedelic compound currently in Phase 2 development for the treatment of major depressive disorder (MDD). Bretisilocin is ...
GEN

AbbVie Embraces Psychedelic Drug with Up-to-$1.2B Deal for Gilgamesh’s MDD Candidate

AbbVie has agreed to acquire Gilgamesh Pharmaceuticals’ lead pipeline asset bretisilocin, a clinical-stage candidate designed to treat moderate-to-severe major depressive disorder (MDD), for up to ...
The Business Journals

AbbVie's latest acquisition targets Gilgamesh's psychedelic drug to treat depression

To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min AbbVie is making a billion ...